Correction
Published on 06 Sep 2023
Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
in Cancer Immunity and Immunotherapy
- 534 views
Correction
Published on 06 Sep 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 06 Sep 2023
in Cancer Immunity and Immunotherapy

Original Research
Published on 06 Sep 2023
in Cancer Immunity and Immunotherapy

Review
Published on 06 Sep 2023
in Cancer Immunity and Immunotherapy

Review
Accepted on 04 Sep 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy

Review
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy

Original Research
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy

Brief Research Report
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy

Retraction
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy
Retraction
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy

Review
Published on 04 Sep 2023
in Cancer Immunity and Immunotherapy

Original Research
Published on 01 Sep 2023
in Cancer Immunity and Immunotherapy

Review
Published on 01 Sep 2023
in Cancer Immunity and Immunotherapy

Review
Published on 01 Sep 2023
in Cancer Immunity and Immunotherapy
